ClinicalTrials.Veeva

Find clinical trials for Adenocarcinoma in Los Angeles, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Prostatic Cancer
Esophageal Cancer

Adenocarcinoma trials near Los Angeles, CA, USA:

Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma

pembrolizumab in subjects with advanced gastric and gastroesophageal adenocarcinoma. These are subjects who have progressed, or not tolerate...

Active, not recruiting
Gastric Adenocarcinoma
GastroEsophageal Cancer
Drug: Pembrolizumab
Drug: Cabozantinib

Phase 2

University of California Irvine (UCI)
University of California Irvine (UCI)

Orange, California, United States

with chemotherapy and chemoradiation in locally advanced esophageal adenocarcinoma to examine the safety and efficacy of the combination of ...

Active, not recruiting
Esophageal Adenocarcinoma
Drug: Carboplatin
Drug: Pembrolizumab

Phase 2

Weill Cornell Medicine (WCM)
Weill Cornell Medicine (WCM)

Los Angeles, California, United States and 3 other locations

for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery operated device for ...

Active, not recruiting
Pancreas Adenocarcinoma
Drug: Gemcitabine
Drug: nab paclitaxel

Phase 3

NovoCure
NovoCure

Los Angeles, California, United States and 197 other locations

This study will test the effectiveness (anti-tumor activity), safety, and ability to increase the body's immune system to fight pancreatic cancer by...

Enrolling
Pancreatic Ductal Adenocarcinoma
Resectable Pancreatic Ductal Adenocarcinoma (PDAC)
Drug: Pembrolizumab
Drug: Defactinib

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Los Angeles, California, United States and 1 other location

to evaluate the safety and efficacy of first-line chemo-immunotherapy combinations in participants with metastatic pancreatic ductal adenocarcinoma...

Active, not recruiting
Metastatic Pancreatic Adenocarcinoma
Drug: Nab-paclitaxel (nP) (Cohort A, B and C)
Drug: Gemcitabine (gem) (Cohort A, B and C)

Phase 1

Cancer Insight

Los Angeles, California, United States and 5 other locations

determining the efficacy of adjuvant trifluridine and tipiracil (TAS-102) in combination with irinotecan in patients with ctDNA positive colon adenocarcinoma...

Enrolling
Colon Adenocarcinoma
Colorectal Cancer
Diagnostic Test: Signatera MRD ctDNA Assay
Drug: TAS-102

Phase 1

University of California Irvine (UCI)
University of California Irvine (UCI)

Orange, California, United States

42,000-lipase units (capsules), for snacks, are added to standard of care in patients with exocrine pancreatic insufficiency due to pancreatic adenocarcinoma...

Enrolling
Pancreatic Adenocarcinoma
Drug: Pancrelipase

Phase 2

Andrew Hendifar, MD

Los Angeles, California, United States

The goal of this clinical trial is to determine clinical advantages for LP-300 in combination with carboplatin and pemetrexed in the never smoker pat...

Enrolling
Adenocarcinoma of Lung
Carcinoma, Non-Small-Cell Lung
Drug: Pemetrexed
Drug: Carboplatin

Phase 2

Lantern Pharma

Los Angeles, California, United States and 11 other locations

and immunogenicity of novel combination therapies in participants with locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma...

Enrolling
Gastric Cancer
Drug: 5-Fluorouracil
Drug: AZD0901

Phase 2

AstraZeneca
AstraZeneca

Los Angeles, California, United States and 42 other locations

combinations in participants with metastatic Pancreatic Ductal Adenocarcinoma (PDAC).Two cohorts will be enrolled in parallel in this study:...

Active, not recruiting
Pancreatic Adenocarcinoma
Drug: Fluorouracil
Drug: RO6874281

Phase 1, Phase 2

Roche
Roche

Duarte, California, United States and 26 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems